Literature DB >> 9045666

Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation.

K M Koli, C L Arteaga.   

Abstract

Three cell surface transforming growth factor beta (TGFbeta) receptor (R) proteins regulate the effects of TGFbeta isoforms on growth and differentiation. TGFbeta-IR and -IIR are transmembrane serine/threonine kinases directly mediating the signaling across the plasma membrane. Both TGFbeta and its receptors are ubiquitously expressed, hence the fine regulation of the multiplicity of responses most likely involves several levels of control including the regulation of expression, complex formation, and down-regulation of the receptor proteins. In mink lung epithelial cells, TGFbeta-IIR was first synthesized as a approximately 60-kDa endoglycosidase H-sensitive precursor protein, which was converted to a mature approximately 70-kDa protein. The half-life of metabolically labeled mature TGFbeta-IIR was estimated to be 60 min and was further reduced to approximately 45 min in the presence of exogenous TGFbeta1. Minimal internalization of 125I-TGFbeta1 at 37 degrees C was detected suggesting that the rapid turnover was not due to endocytosis and degradation of the ligand-receptor complexes. TGFbeta-IR was synthesized as a approximately 53-kDa precursor protein, which was processed to a mature approximately 55-kDa receptor protein. The half-life of TGFbeta-IR was >12 h. A fraction of tunicamycin-treated type I and II receptors that reach the cell surface was able to associate in the presence of ligand suggesting that heteromeric complexes can form in a post-endoplasmic reticulum compartment before full glycosylation is achieved. These results show differential processing and turnover of TGFbeta-IR and TGFbeta-IIR providing a potential additional mechanism for modulation of cellular responses to TGFbetas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045666     DOI: 10.1074/jbc.272.10.6423

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

2.  Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.

Authors:  Tal Hirschhorn; Michal Levi-Hofman; Oded Danziger; Nechama I Smorodinsky; Marcelo Ehrlich
Journal:  Cell Mol Life Sci       Date:  2017-03-29       Impact factor: 9.261

3.  SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.

Authors:  Sheng Liu; Thao Nheu; Rodney Luwor; Sandra E Nicholson; Hong-Jian Zhu
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

4.  TGF-beta1 in Aplysia: role in long-term changes in the excitability of sensory neurons and distribution of TbetaR-II-like immunoreactivity.

Authors:  J Chin; A Angers; L J Cleary; A Eskin; J H Byrne
Journal:  Learn Mem       Date:  1999 May-Jun       Impact factor: 2.460

5.  Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.

Authors:  Gang Chen; Paritosh Ghosh; Dan L Longo
Journal:  Mol Cancer Res       Date:  2010-12-03       Impact factor: 5.852

6.  BMP signaling requires retromer-dependent recycling of the type I receptor.

Authors:  Ryan J Gleason; Adenrele M Akintobi; Barth D Grant; Richard W Padgett
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.

Authors:  Chunsheng Liu; Daniel D Billadeau; Haitham Abdelhakim; Edward Leof; Kozo Kaibuchi; Carmelo Bernabeu; George S Bloom; Liu Yang; Lisa Boardman; Vijay H Shah; Ningling Kang
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

8.  Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints.

Authors:  Hwa-Seon Seo; Rosa Serra
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

9.  Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors.

Authors:  R A Anders; S L Arline; J J Doré; E B Leof
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

10.  Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11.

Authors:  Hugh Mitchell; Amit Choudhury; Richard E Pagano; Edward B Leof
Journal:  Mol Biol Cell       Date:  2004-06-30       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.